U.S. Health & Human Services
U.S. HHS secretary issues progress report on Medicare Prescription Drug Benefit
Published in Managed Care Law Weekly, March 5th, 2006
The report details action steps HHS and health plans are taking, such as extending transition coverage for a beneficiary's current drugs to 90 days and reducing call wait times. The report also includes new estimates showing the costs of the Medicare drug benefit are significantly less than expected.
"While the new prescription drug benefit has worked for the vast majority of participants, the first trip to the pharmacy has been frustrating for some, particularly for certain people with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
More Articles from Managed Care Law Weekly
- Healthcare Costs
Pediatricians vote to cut children's healthcare - Healthcare Coverage
Reimbursement for minimally invasive procedures often pays surgeons less, study shows - Pediatrics
Children's asthma care improves on state health insurance program - ACT Health
Early pertussis diagnosis may limit transmission and protect susceptible infants - ActivBiotics, Inc.
U.S. FDA fast track status granted for rifalazil in peripheral arterial disease - Adventrx Pharmaceuticals, Inc.
Thiovir proven active against various influenza A viruses - More from this issue of Managed Care Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
